advertisement
ACT
advertisement

May 5/2020

news roundup

Cerner Provides De-identified Patient Data Toward COVID

Cerner Corporation is offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic.



PHARMASEAL Expands Engility Platform

PHARMASEAL is expanding the capability of the Engility platform. Electronic trial master file document(eTMF) storage is now available alongside Clinical Trial Management in the same integrated platform.


Pharm-Olam, IACOR Collaborate on Audit Certification

Pharm-Olam developed a 12-week program, Core Global Competencies for Clinical Research Auditing, which IACOR has independently accredited to ensure consistently high standards of clinical research auditing across the industry.


Join CISCRP’s Virtual Medical Hero Appreciation Fitness Challenge!

There is still time to register and participate in the virtual The 2nd Annual Medical Hero Appreci-a-thon to express appreciation for all “Medical Heroes”—medical and healthcare professionals, researchers and study volunteers.


Articles

A New Approach to Risk-Balanced Contracting

In this article, the author proposes a risk-balanced approach to outsource clinical studies, which requires both parties to be transparent, objective, and work collaboratively early in the outsourcing process.


Overcoming Challenges in Observational Patient Registries

In this interview, Ravi Jandhyala, consultant pharmaceutical physician at Medialis and an expert in rare disease patient registries, discusses how to overcome clinical trial registry challenges.


In this edition

A New Approach to Risk-Balanced Contracting
The Beginning of the End of Clinical Trials As We Know Them?


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »

Events

DIA 2020 Global Annual Meeting, Now Virtual
Search Upcoming Events
 

Blog Posts

The Beginning of the End of Clinical Trials As We Know Them?

COVID-19 will not only leave a long legacy on public health, but it may also force companies that have been lagging behind the disruption curve to adopt technologies and processes that will make clinical trials more efficient.

The Need for Virtual Trials: A Site’s Perspective

Vivienne van de Walle, MD, PhD, CPI, FAPCR is co-founder and owner of PT&R (PreCare Trial & Recruitment), an independent research site in The Netherlands, and has been an advocate for virtual site visits over the past five plus years. Read more about her thoughts on virtual trials.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mjhlifesciences.com

Advertise

Todd Baker
Group Publisher
TBaker@mjhlifesciences.com